New TB vaccine granted orphan drug status.

New TB vaccine granted orphan drug status.

書誌詳細
主要な著者:	Lang, T, Hill, A, Mcshane, H, Shah, R, Towse, A, Pritchard, C, Garau, M
フォーマット:	Journal article
言語:	English
出版事項:	2005

類似資料

Towards new TB vaccines
著者:: Brazier, B, 等
出版事項: (2020)

Market-driven, value-based, advance commitment (MVAC): accelerating the development of a pathbreaking universal drug regimen to end TB
著者:: Kalipso Chalkidou, 等
出版事項: (2020-04-01)

TB vaccines in clinical development
著者:: Ginsberg, A, 等
出版事項: (2016)

TB vaccines in clinical development
著者:: Ginsburg, A, 等
出版事項: (2016)

DEVELOPING A NEW TB VACCINE: BOOSTING BCG WITH MVA85A
著者:: Mcshane, H
出版事項: (2008)

Need for more TB vaccine field sites.
著者:: Mcshane, H
出版事項: (2009)

Development of Orphan Vaccines: An Industry Perspective
著者:: Jean Lang, 等
出版事項: (1999-12-01)

TB vaccines in clinical development
著者:: Ginsberg, AM, 等
出版事項: (2016)

Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A.
著者:: Whelan, K, 等
出版事項: (2009)

Preclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacy.
著者:: Minassian, A, 等
出版事項: (2011)

Differential cytokine levels in adults induced by a Novel candidate TB boost vaccine, MVA85A-according to previous BCG vaccination status
著者:: Owiafe, P, 等
出版事項: (2012)

Implementation status of pharmacological studies in the development of orphan drugs
著者:: Saki Yokoshiki, 等
出版事項: (2024-01-01)

TB vaccine development: where are we and why is it so difficult?
著者:: Wilkie, M, 等
出版事項: (2014)

Progress and challenges in TB vaccine development
著者:: Voss, G, 等
出版事項: (2018)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults.
著者:: Pathan, A, 等
出版事項: (2012)

NOW THE SOLUTION IS HERE – SOCIAL ASSISTANCE FOR ORPHANED CHILDREN: THE EXTENDED CHILD SUPPORT GRANT
著者:: Sipho Sibanda, 等
出版事項: (2023-04-01)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults
著者:: Pathan, A, 等
出版事項: (2012)

A review of clinical models for the evaluation of human TB vaccines.
著者:: O'Shea, M, 等
出版事項: (2016)

Advances in orphan drug development: Time to change the status and stereotype
著者:: Sayanta Thakur
出版事項: (2022-01-01)

Current status and trend of clinical development of orphan drugs in China
著者:: Ziling Xiang, 等
出版事項: (2022-07-01)

Cancer drug funding decisions in Scotland: impact of new end-of-life, orphan and ultra-orphan processes
著者:: Morrell, L, 等
出版事項: (2017)

Orphan drugs and rare diseases /
著者:: Pryde, David C., editor, 等
出版事項: (2014)

Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A.
著者:: Kathryn T. Whelan, 等
出版事項: (2011-01-01)

Donor investment choices in developing countries: a methodology and some illustrative results based on Public-Private partnerships for product development (PD PPPs)
著者:: Gray, A, 等
出版事項: (2007)

Current Status and Prospect of Orphan Drugs for Rare Skin Diseases in China
著者:: ZHANG Shan, 等
出版事項: (2023-04-01)

A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants
著者:: Odutola, A, 等
出版事項: (2012)

A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants.
著者:: Odutola, A, 等
出版事項: (2012)

Mechanism of coordinated access to orphan drugs
著者:: DeRidder R, 等
出版事項: (2012-11-01)

International comparison of availability for orphan drugs: focused on approved orphan drugs in South Korea
著者:: Eun Young Shin, 等
出版事項: (2024-12-01)

Cancer drug funding decisions in Scotland: impact of new end-of-life, orphan and ultra-orphan processes
著者:: Liz Morrell, 等
出版事項: (2017-08-01)

FDA orphan products clinical trial grants: assessment of outcomes and impact on rare disease product development
著者:: Kathleen L. Miller, 等
出版事項: (2020-09-01)

Rare diseases and orphan drugs.
著者:: Aronson, J
出版事項: (2006)

A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data.
著者:: McShane, H, 等
出版事項: (2014)

A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data
著者:: McShane, H, 等
出版事項: (2014)

Orphan drugs’ clinical uncertainty and prices: Addressing allocative and technical inefficiencies in orphan drug reimbursement
著者:: Hans-Georg Eichler, 等
出版事項: (2023-01-01)

Adenylosuccinic Acid: An Orphan Drug with Untapped Potential
著者:: Emma Rybalka, 等
出版事項: (2023-05-01)

Financing drug discovery for orphan diseases
著者:: Gromatzky, Austin A., 等
出版事項: (2014)

Sea Grant seeks new drugs from the sea
著者:: W Fenical
出版事項: (1997-07-01)

Sea Grant seeks new drugs from the sea
著者:: William Fenical
出版事項: (1997-07-01)

Status of orphan children in Ukraine in war
著者:: Andrukhiv O.
出版事項: (2022-06-01)